BTIG Research Reaffirms Neutral Rating for P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ:PIII)‘s stock had its “neutral” rating restated by research analysts at BTIG Research in a research report issued on Friday,Benzinga reports.

Other equities research analysts have also recently issued reports about the stock. Lake Street Capital reduced their target price on shares of P3 Health Partners from $20.00 to $12.50 and set a “buy” rating for the company in a report on Monday, November 17th. Weiss Ratings restated a “sell (e+)” rating on shares of P3 Health Partners in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.50.

P3 Health Partners Stock Performance

Shares of PIII opened at $5.11 on Friday. The company’s 50 day simple moving average is $7.32 and its 200-day simple moving average is $7.31. The firm has a market cap of $36.84 million, a PE ratio of -0.13 and a beta of 0.87. P3 Health Partners has a 12-month low of $4.97 and a 12-month high of $14.50. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 2.29.

P3 Health Partners (NASDAQ:PIII) last released its quarterly earnings results on Thursday, November 13th. The company reported ($9.67) EPS for the quarter, missing the consensus estimate of ($8.70) by ($0.97). The business had revenue of $345.25 million during the quarter, compared to analysts’ expectations of $346.64 million. P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. As a group, equities analysts predict that P3 Health Partners will post -0.67 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC increased its holdings in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 22.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,278,037 shares of the company’s stock after acquiring an additional 234,500 shares during the period. Trinity Financial Advisors LLC owned approximately 17.80% of P3 Health Partners worth $222,000 as of its most recent SEC filing. 7.75% of the stock is currently owned by institutional investors.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.